Table 1 General characteristics of studies meeting inclusion criteria
From: The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis
Study | Country (years of costing) | Type of assessed cost | ||
|---|---|---|---|---|
Direct medical cost | Direct nonmedical cost | Indirect cost | ||
Top-down studies | ||||
Viscusi et al. (2021) [36] | USA (2020) | No | No | Yes |
Santos et al. (2021) [37] | Brazil (2020) | Yes | No | No |
Zhao et al. (2021) [38] | China (2019) | Yes | Yes | Yes |
John et al. (2021) [39] | India (2020) | No | No | Yes |
Nurchis et al. (2020) [40] | Italy (2020) | No | No | Yes |
Gonzalez Lopez et al. (2020) [41] | Spain (2020) | Yes | Yes | Yes |
Debone et al. (2020) [42] | Brazil (2020) | No | No | Yes |
Bottom-up studies | ||||
Jeck et al. (2021) [18] | Germany (2020) | Yes | No | No |
Kotwani et al. (2021) [19] | India (2021) | Yes | Yes | Yes |
Tsai et al. (2021) [20] | USA (2020) | Yes | No | No |
Nguyen et al. (2021) [35] | USA (2021) | Yes | No | No |
Weiner et al. (2021) [21] | USA (2020) | Yes | No | No |
Fusco et al. (2021) [22] | USA (2020) | Yes | No | No |
Edoka et al. (2021) [23] | South Africa (2020) | Yes | No | No |
Tabuñar et al. (2021) [24] | Philippines (2020) | Yes | No | No |
Zhao et al. (2021) [25] | China (2020) | Yes | No | No |
Maltezou et al. (2021) [10] | Greece (2020) | Yes | Yes | Yes |
Ghaffari Darab et al. (2021) [43] | Iran (2020) | Yes | No | Yes |
Barasa et al. (2021) [27] | Kenya (2020) | Yes | No | No |
Seon et al. (2021) [28] | South Korea (2020) | Yes | No | No |
Banke-Thomas et al. (2021) [29] | Nigeria (2020) | Yes | Yes | Yes |
Li et al. (2020) [30] | China (2020) | Yes | No | No |
Jin et al. (2020) [7] | China (2019) | Yes | No | Yes |
Kirigia et al. (2020) [31] | China (2020) | No | No | Yes |
Lee et al. (2020) [32] | South Korea (2020) | Yes | No | No |
Khan et al. (2020) [33] | Kingdom of Saudi Arabia (2020) | Yes | No | No |
Romero et al. (2020) [34] | Spain (2020) | Yes | Yes | Yes |